The use of Invivofectamine reagent as a means to deliver nucleic acid to the eye for treatment of Age-Related Macular Degeneration

Researchers

Grant status

Completed

Grant start date

01/05/2015

Grant funding

  • 2015: $6,453 from Thermo Fisher Scientific Inc

Updated:  05 August 2021 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers